Oncology

Astellas is already a proven player in the fields of Transplantation, Urology and Anti-Infectives – a position we have achieved through a commitment to innovation. We are now bringing this expertise to bear in the field of oncology.

With a strong commitment to research and development, we are dedicated to building a strong presence in this most challenging of therapeutic areas where a high level of unmet medical need exists.

Our mission is, to play a key role in the advancement of oncology treatments, with a positive look to the future. Astellas Pharma is committed to making every endeavour to provide products that are recognised worldwide as improving outcomes for patients in every way possible following diagnosis of metastatic castration resistance prostate cancer mCRPC.

As a leading pharmaceutical company, Astellas Pharma is committed to providing medicines for mCRPC both before & after chemotherapy. Astellas Pharma is committed to making every endeavour to provide products that improve outcomes for patients in every way possible following a diagnosis of mCRPC.

APCL18001IRE(b)